First Trust Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.6M | Buy |
|
|||||
|
2025
Q1 | $72.3M | Sell |
|
|||||
|
2024
Q4 | $194M | Sell |
|
|||||
|
2024
Q3 | $307M | Sell |
|
|||||
|
2024
Q2 | $381M | Buy |
|
|||||
|
2024
Q1 | $324M | Sell |
|
|||||
|
2023
Q4 | $321M | Buy |
|
|||||
|
2023
Q3 | $140M | Buy |
|
|||||
|
2023
Q2 | $116M | Sell |
|
|||||
|
2023
Q1 | $184M | Buy |
|
|||||
|
2022
Q4 | $144M | Sell |
|
|||||
|
2022
Q3 | $312M | Buy |
|
|||||
|
2022
Q2 | $236M | Buy |
|
|||||
|
2022
Q1 | $121M | Sell |
|
|||||
|
2021
Q4 | $129M | Buy |
|
|||||
|
2021
Q3 | $120M | Buy |
|
|||||
|
2021
Q2 | $96.2M | Sell |
|
|||||
|
2021
Q1 | $82.4M | Buy |
|
|||||
|
2020
Q4 | $78.2M | Sell |
|
|||||
|
2020
Q3 | $204M | Buy |
|
|||||
|
2020
Q2 | $224M | Buy |
|
|||||
|
2020
Q1 | $122M | Sell |
|
|||||
|
2019
Q4 | $115M | Buy |
|
|||||
|
2019
Q3 | $82.2M | Sell |
|
|||||
|
2019
Q2 | $109M | Sell |
|
|||||
|
2019
Q1 | $148M | Buy |
|
|||||
|
2018
Q4 | $109M | Buy |
|
|||||
|
2018
Q3 | $117M | Buy |
|
|||||
|
2018
Q2 | $64.9M | Buy |
|
|||||
|
2018
Q1 | $51M | Buy |
|
|||||
|
2017
Q4 | $45.7M | Sell |
|
|||||
|
2017
Q3 | $66.8M | Buy |
|
|||||
|
2017
Q2 | $54.2M | Buy |
|
|||||
|
2017
Q1 | $36.3M | Sell |
|
|||||
|
2016
Q4 | $45.5M | Buy |
|
|||||
|
2016
Q3 | $34.6M | Sell |
|
|||||
|
2016
Q2 | $30.3M | Sell |
|
|||||
|
2016
Q1 | $58.2M | Sell |
|
|||||
|
2015
Q4 | $197M | Sell |
|
|||||
|
2015
Q3 | $198M | Sell |
|
|||||
|
2015
Q2 | $238M | Buy |
|
|||||
|
2015
Q1 | $209M | Buy |
|
|||||
|
2014
Q4 | $136M | Buy |
|
|||||
|
2014
Q3 | $87.1M | Sell |
|
|||||
|
2014
Q2 | $79.8M | Buy |
|
|||||
|
2014
Q1 | $77M | Sell |
|
|||||
|
2013
Q4 | $78.6M | Sell |
|
|||||
|
2013
Q3 | $91.5M | Buy |
|
|||||
|
2013
Q2 | $43.1M | Buy |
|